VYNE · CIK 0001566044 · operating
VYNE Therapeutics Inc. (VYNE) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $20 million, VYNE Therapeutics Inc. is a micro-cap company. The stock currently trades at $0.60, up 0.75% today, with a 52-week range of $0.28–$2.60.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-0.62 | $-0.62 | +33.3% | |
| 2024 | $-0.93 | $-0.93 | +66.5% | |
| 2023 | $-2.78 | $-2.78 | +61.8% | |
| 2022 | $-7.28 | $-7.28 | -612.7% | |
| 2021 | $1.42 | $1.42 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-27 | 0001566044-26-000002 | SEC ↗ |
| 2024-12-31 | 2025-03-06 | 0001628280-25-010908 | SEC ↗ |
| 2023-12-31 | 2024-03-01 | 0001628280-24-008178 | SEC ↗ |
| 2022-12-31 | 2023-03-14 | 0001628280-23-007900 | SEC ↗ |
| 2021-12-31 | 2022-03-17 | 0001628280-22-006545 | SEC ↗ |
| 2020-12-31 | 2021-03-04 | 0001566044-21-000010 | SEC ↗ |
| 2019-12-31 | 2020-03-03 | 0001564590-20-008442 | SEC ↗ |
| 2018-12-31 | 2019-02-28 | 0001564590-19-005451 | SEC ↗ |
| 2017-12-31 | 2018-03-28 | 0001628280-18-003726 | SEC ↗ |